ORIFARM GENERICS HOLDING A/S — Credit Rating and Financial Key Figures

ORIFARM GENERICS HOLDING A/S (CVR number: 27347223K) is a company from ODENSE. The company reported a net sales of 77.2 mEUR in 2018, demonstrating a growth of 0.6 % compared to the previous year. The operating profit percentage was at 11.3 % (EBIT: 8.7 mEUR), while net earnings were 5504 kEUR. The profitability of the company measured by Return on Assets (ROA) was 9.5 %, which can be considered good and Return on Equity (ROE) was 14.8 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 35.3 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. ORIFARM GENERICS HOLDING A/S's liquidity measured by quick ratio was 0.4 which is at a very low level. Thus, the company is in an unstable financial position, with its liquid assets significantly undermatching its current liabilities. This severe liquidity deficiency may lead to financial distress and threaten the company's operational continuity.